The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

Clinical trial NCT06434467 · UNKNOWN

Trial details

NCT number: NCT06434467
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

T-lymphoblastic Leukemia T-lymphoblastic Lymphoma

Start date: 2024-05-01
Primary completion: 2025-12-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.